logo

AUPH

Aurinia·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

AUPH fundamentals

Aurinia (AUPH) released its earnings on Nov 4, 2025: revenue was 73.47M (YoY +8.41%), beat estimates; EPS was 0.23 (YoY +130.00%), beat estimates.
Revenue / YoY
73.47M
+8.41%
EPS / YoY
0.23
+130.00%
Report date
Nov 4, 2025
AUPH Earnings Call Summary for Q3,2025
  • Revenue Beat: Q3 sales up 27% YoY, pushing 2025 guidance to $275-280M
  • Clinical Win: LUPKYNIS reduces renal events by 53%, aritinercept Phase I shows strong safety
  • Pipeline Expansion: Aritinercept moving into 2 autoimmune disease studies by year-end
  • Cash Flow Strength: +162% YoY operating cash flow to $44.5M
EPS
Revenue

Revenue & Expenses

AUPH has released its 2025 Q3 earnings report, with revenue of 73.47M, reflecting a YoY change of 8.41%, and net profit of 31.55M, showing a YoY change of 119.87%. The Sankey diagram below clearly presents AUPH's revenue sources and cost distribution.

Key Indicators

Aurinia (AUPH) key financial stats and ratios, covering profitability, financial health, and leverage.
Aurinia (AUPH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aurinia (AUPH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aurinia (AUPH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aurinia (AUPH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aurinia (AUPH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield